167 related articles for article (PubMed ID: 35434031)
1. Hypomethylation-induced prognostic marker zinc finger DHHC-type palmitoyltransferase 12 contributes to glioblastoma progression.
Lu F; Shen SH; Wu S; Zheng P; Lin K; Liao J; Jiang X; Zeng G; Wei D
Ann Transl Med; 2022 Mar; 10(6):334. PubMed ID: 35434031
[TBL] [Abstract][Full Text] [Related]
2. Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression.
Tang F; Yang C; Li FP; Yu DH; Pan ZY; Wang ZF; Li ZQ
Mol Ther Nucleic Acids; 2022 Jun; 28():716-731. PubMed ID: 35664705
[TBL] [Abstract][Full Text] [Related]
3. Bromodomain containing 4 transcriptionally activated Deltex E3 ubiquitin ligase 2 contributes to glioma progression and predicts an unfavorable prognosis.
Wu S; Shen SH; Lu F; Zheng P; Lin K; Liao J; Jiang X; Zeng G; Wei D
Ann Transl Med; 2022 Mar; 10(6):313. PubMed ID: 35434025
[TBL] [Abstract][Full Text] [Related]
4. ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma.
Liu ZY; Lan T; Tang F; He YZ; Liu JS; Yang JZ; Chen X; Wang ZF; Li ZQ
BMC Cancer; 2023 May; 23(1):420. PubMed ID: 37161425
[TBL] [Abstract][Full Text] [Related]
5. ZDHHC12-mediated claudin-3
Yuan M; Chen X; Sun Y; Jiang L; Xia Z; Ye K; Jiang H; Yang B; Ying M; Cao J; He Q
Acta Pharm Sin B; 2020 Aug; 10(8):1426-1439. PubMed ID: 32963941
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of palmitoyltransferase ZDHHC12 sensitizes ovarian cancer cells to cisplatin through ROS-mediated mechanisms.
Zhang X; Liao X; Wang M; Liu J; Han J; An D; Zheng T; Wang X; Cheng H; Liu P
Cancer Sci; 2024 Apr; 115(4):1170-1183. PubMed ID: 38287874
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain-containing protein 4 activates cardiotrophin-like cytokine factor 1, an unfavorable prognostic biomarker, and promotes glioblastoma
Shen SH; Guo JF; Huang J; Zhang Q; Cui Y
Ann Transl Med; 2022 Apr; 10(8):475. PubMed ID: 35571403
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
[TBL] [Abstract][Full Text] [Related]
9. [The effect of HOXC10 gene on biological behaviors of glioma cells and mechanism in tumor microenvironment].
Jiang WY; Lei QY; Liu SS; Yang L; Yang B; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):228-237. PubMed ID: 35316872
[No Abstract] [Full Text] [Related]
10. Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.
Xia L; Jin P; Tian W; Liang S; Tan L; Li B
Braz J Med Biol Res; 2021; 54(7):e10236. PubMed ID: 34008750
[TBL] [Abstract][Full Text] [Related]
11. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
12. NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas.
Sun H; Long S; Wu B; Liu J; Li G
PeerJ; 2020; 8():e8787. PubMed ID: 32211242
[TBL] [Abstract][Full Text] [Related]
13. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
14. A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
Cai X; Qiu W; Qian M; Feng S; Peng C; Zhang J; Wang Y; Wang Y
Front Cell Dev Biol; 2020; 8():615970. PubMed ID: 33614625
[No Abstract] [Full Text] [Related]
15. A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients.
Bai YH; Zhan YB; Yu B; Wang WW; Wang L; Zhou JQ; Chen RK; Zhang FJ; Zhao XW; Duan WC; Wang YM; Liu J; Bao JJ; Zhang ZY; Liu XZ
Cell Physiol Biochem; 2018; 48(4):1755-1770. PubMed ID: 30078018
[TBL] [Abstract][Full Text] [Related]
16. COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
Wang H; Liu Z; Li A; Wang J; Liu J; Liu B; Lian X; Zhang B; Pang B; Liu L; Gao Y
Exp Ther Med; 2021 Nov; 22(5):1224. PubMed ID: 34539820
[TBL] [Abstract][Full Text] [Related]
17. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
18. High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.
Yu K; Ji Y; Liu M; Shen F; Xiong X; Gu L; Lu T; Ye Y; Feng S; He J
Front Immunol; 2022; 13():881453. PubMed ID: 35663965
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.
Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L
Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481
[TBL] [Abstract][Full Text] [Related]
20. RGS16 promotes glioma progression and serves as a prognostic factor.
Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]